Client Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international research

Chisholm, Daniel; Knapp, Martín; Knudsen, Helle Charlotte; Amaddeo, Francesco; Gaite, L.; Wijngaarden, Bob van

doi:10.1192/bjp.177.39.s28

Cited by 450 publications

(366 citation statements)

References 16 publications

Supporting

Mentioning

360

Contrasting

Unclassified

Order By: Relevance

“…Participants were asked to report resource use at the baseline, 32, 64 and 96 weeks assessments. Resource use data are collected using and economic patient questionnaire (EPQ) which includes questions from the Client Service Receipt Inventory (CSRI) (26) interview and service use questionnaires used in previous mental health trials (27). At each assessment, participants were asked to recall their use of health and social care services since the previous scheduled assessment (or 6-months before baseline).…”

Section: Measuring Costsmentioning

confidence: 99%

Cost-effectiveness of structured group psychoeducation versus unstructured group support for bipolar disorder: Results from a multi-centre pragmatic randomised controlled trial

Camacho

Ntais

Jones

et al. 2017

Journal of Affective Disorders

View full text Add to dashboard Cite

Background Bipolar disorder (BD) costs the English economy an estimated £5.2billion/year, largely through incomplete recovery. This analysis estimated the cost-effectiveness of group psychoeducation (PEd), versus group peer support (PS), for treating BD. Methods A 96-week pragmatic randomised controlled trial (RCT), conducted in NHS primary care. The primary analysis compared PEd with PS, using multiple imputed datasets for missing values. An economic model was used to compare PEd with treatment as usual (TAU). The perspective was Health and Personal Social Services. Results Participants receiving PEd (n=153) used more (costly) health-related resources than PS (n=151) (net cost per person £1098 (95% CI, £252-£1943)), with a quality-adjusted life year (QALY) gain of 0.023 (95% CI, 0.001-0.056). The cost per QALY gained was £47,739. PEd may be costeffective (versus PS) if decision makers are willing to pay at least £37,500 per QALY gained. PEd costs £10,765 more than PS to avoid one relapse. The economic model indicates that PEd may be costeffective versus TAU if it reduces the probability of relapse (by 15%) or reduces the probability of and increases time to relapse (by 10%). Limitations Participants were generally inconsistent in attending treatment sessions and low numbers had complete cost/QALY data. Factors contributing to pervasive uncertainty of the results are discussed. Conclusions This is the first economic evaluation of PEd versus PS in a pragmatic trial. PEd is associated with a modest improvement in health status and higher costs than PS. There is a high level of uncertainty in the data and results.

show abstract

Section: Measuring Costsmentioning

confidence: 99%

Cost-effectiveness of structured group psychoeducation versus unstructured group support for bipolar disorder: Results from a multi-centre pragmatic randomised controlled trial

Camacho

Ntais

Jones

et al. 2017

Journal of Affective Disorders

View full text Add to dashboard Cite

show abstract

“…18 The CSRI version used in this study was designed to collect data on health services utilisation during the previous 12 months. For the purposes of the present work, only face-to-face contacts between patients and GPs from the public sector were taken into account.…”

Section: Survey Instrumentsmentioning

confidence: 99%

Frequent attendance in primary care: comparison and implications of different definitions

Luciano¹,

Fernández²,

Pinto‐Meza³

et al. 2010

Br J Gen Pract

View full text Add to dashboard Cite

The diversity of definitions of frequent attendance in the literature hampers comparison of their precision, validity, and associated factors. AimTo examine different definitions of frequent attendance in order to identify the sociodemographic and clinical factors associated with frequent attendance in primary care, according to each definition. Design of studyOne-phase cross-sectional study. SettingSeventy-seven primary care centres in Catalonia, Spain. MethodA total of 3815 primary care patients were interviewed between October 2005 and March 2006. Three definitions of frequent attendance were tested: (1) frequent attenders as the top 25% and the top 10% consulting patients; (2) frequent attenders as the top 25% and the top 10% consulting patients stratified by age and sex; and (3) frequent attenders as the top 25% and the top 10% consulting patients stratified by the presence of physical/mental conditions (patients with only mental disorders, with only chronic physical conditions, with comorbid conditions, and with no condition). Multilevel logistic regressions were used. ResultsThe following factors were systematically related to frequent attender status: being on sick leave, being born outside of Spain, reporting mental health problems as the main reason for consulting, and having arthritis/rheumatism, or bronchitis. Major depression was related to frequent attendance in two of the three definitions. The factor 'GP' was related to frequent attendance when the top decile cut-off point was used. The models with a 10% cut-off point were more discriminative than those with a 25% cut-off point: the area under the receiver operating characteristic curve for models with a 25% cut-off and a 10% cut-off ranged between 0.71 (95% confidence interval [CI] = 0.70 to 0.73) and 0.75 (95% CI = 0.74 to 0.77) and between 0.79 (95% CI = 0.78 to 0.81) and 0.85 (95% CI = 0.83 to 0.86), respectively. ConclusionThe way frequent attendance is defined is of crucial importance. It is recommended that a more discriminative definition of frequent attendance is used (the top 10%).

show abstract

“…• Study clients' use of mental health care services was recorded continuously for twelve months with the Service Utilization Sheet (SUS), which adapted the service items and definitions of the Client Socio-demographic and Service Receipt Inventory (CSSRI) (Chisholm et al 2000) and of the European Service Mapping Schedule (ESMS) (Johnson et al, 2000).…”

Section: Assessmentsmentioning

confidence: 99%

Cost of treatment of schizophrenia in six European countries

Salize

McCabe

Bullenkamp

et al. 2009

Schizophrenia Research

View full text Add to dashboard Cite

Background and aims:As part of a RCT in six European sites, the direct mental health care cost for 422 patients with schizophrenia was analysed according to how total, and medication costs differed across sites and which variables were likely to predict total or service-specific costs.Method: Service use was recorded continuously during a 12-month follow-up. Prescribed psychotropic medication was recorded at baseline and 12 months later. Service use data were transformed into EURO, log-transformed and analysed using linear regression models. Results:Although samples were homogeneous, large inter-site cost differences were found (annual means ranging from 2,958 € in Spain up to 36,978 € in Switzerland). Psychopharmacologic costs were much more constant across sites than costs for other services. Total costs were associated more with region or socio-demographic characteristics than with disorder related parameters. Conclusions:The findings confirm remarkable differences in direct costs of patients wit schizophrenia across Europe. However, the relative stability of medication costs suggests a need to analyse mechanisms that influence service specific costs for schizophrenia.

show abstract

Client Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international research

Cited by 450 publications

References 16 publications

Cost-effectiveness of structured group psychoeducation versus unstructured group support for bipolar disorder: Results from a multi-centre pragmatic randomised controlled trial

Cost-effectiveness of structured group psychoeducation versus unstructured group support for bipolar disorder: Results from a multi-centre pragmatic randomised controlled trial

Frequent attendance in primary care: comparison and implications of different definitions

Cost of treatment of schizophrenia in six European countries

Contact Info

Product

Resources

About